Model for PK/PD of Antimicrobials in Blood Stream Infection: Feasibility

Last updated: January 16, 2020
Sponsor: University of Cologne
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04083443
MOBSI1
  • Ages > 18
  • All Genders

Study Summary

The current study is a pilot study to assess the feasibility of a superordinate project. The final objective of this superordinate project is to describe and model the pharmacokinetic behaviour of a small number of standard antimicrobials used in the treatment of frequent blood stream infections, and to link this via pharmacodynamic models to (inhibition of) bacterial or fungal growth as well as to clinical outcomes in patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • High probability of a blood stream infection; this is based on

  • the presence of SIRS [Bone et al. 1992] defined by more than one of the followingclinical manifestations:

  1. a body temperature greater than 38°C or less than 36°C

  2. a heart rate greater than 90 beats per minute

  3. tachypnea, manifested by a respiratory rate greater than 20 breaths perminute, or hyperventilation, as indicated by a PaCO2 of less than 32 mm Hg

  4. an alteration in the white blood cell count, such as a count greater than 12,000/µl, a count less than 4,000/µl, or the presence of more than 10percent immature neutrophils ("bands"). and

  • the assessment of the treating physician according to the patient's situationthat the SIRS is caused by an infection (e.g., patients after treatment withcytotoxic drugs)

  • indication for antimicrobial treatment

  • Intended use of one of the following antimicrobial agents: piperacillin/tazobactam; vancomycin; meropenem; ampicillin/sulbactam; flucloxacillin;ceftriaxone; caspofungin (according to the decision of the project coordinator, use ofother antimicrobial agents may also be included if anticipated to be used frequently)

  • Age: 18 years or older (no upper limit)

  • Willing and capable to provide written consent prior to enrolment after ampleinformation has been provided

Exclusion

Exclusion Criteria:

  • expected chances to successfully carry out venipunctures to obtain the blood samplesrequired for the study are inadequately low according to the assessment of thephysician

  • Anemia CTCAE grade >2 (i.e., Hb <8.0 g/dL / 4.9 mmol/L)

  • the clinical status of the patients suggests that the anticipated treatment of thepatient or other conditions would make participation on the study inappropriate (e.g.,terminally ill patients); the respective assessment is done by the treating physician

Study Design

Total Participants: 120
Study Start date:
July 23, 2019
Estimated Completion Date:
August 31, 2021

Study Description

Patients with a high probability of a blood stream infection and an indication for antimicrobial treatment will be included. The study comprises the identification of patients as potential study participants, obtaining informed consent, documentation of available potential covariates from patient file, withdrawal of pre-study blood samples (PK, PD, microbiology) including documentation of exact time of sampling and processing of the samples, first drug administration including exact documentation (as part of patient care; not as a study intervention), withdrawal of subsequent blood samples (PK, PD, microbiology) during the next 3 days including documentation of exact time of sampling and processing of the samples, storage of processed samples for further analysis, and, if possible, documentation of patient outcome after 7 days. The following steps are carried out after completion of the clinical part of the study in the individual patient or, when possible, in all patients together or in a subset: Bioanalytics, DNA Counts, assessing primary and secondary study endpoints, pharmacometric analyses including PK parameter estimation, PD parameter estimation and assessment of covariate effects with regard to DNA count, CRP, IL-6 and procalcitonin.

Connect with a study center

  • Klinik für Anaesthesiologie, Klinikum der Ludwig-Maximilians-Universität München

    Munich, Bavaria 81377
    Germany

    Site Not Available

  • Clinical Infectiology, Klinik I für Innere Medizin, University Hospital Cologne

    Cologne, North Rhine-Westphalia 50937
    Germany

    Active - Recruiting

  • Klinik für Anästhesiologie und Operative Intensivmedizin Krankenhaus Köln-Merheim Klinikum der Universität Witten/ Herdecke

    Cologne, North Rhine-Westphalia 51109
    Germany

    Site Not Available

  • Universitätsklinikum Leipzig AöR, Klinik für Gastroenterologie und Rheumatologie, Sektion Hepatologie

    Leipzig, Saxony 04103
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.